Table 2.
Brain volume change on-study: global and regional deep gray matter
| DMF | noDMT | p value | |
|---|---|---|---|
| Thalamus | −0.10 ± 0.28 | −0.04 ± 0.34 | 0.50 |
| Caudate | −0.08 ± 0.12 | −0.01 ± 0.15 | 0.28 |
| Putamen | −0.06 ± 0.22 | −0.32 ± 0.28 | 0.02* |
| Globus pallidus | −0.04 ± 0.11 | −0.04 ± 0.10 | 1.00 |
| Total DGM | −0.28 ± 0.42 | −0.41 ± 0.80 | 0.69 |
| PBVC | −0.37 ± 0.49 | −1.04 ± 0.67 | 0.005* |
Data represent mean ± standard deviation difference between baseline and 1-year follow-up in ml for all variables except for percent whole brain volume change (PBVC), which shows %; DMF dimethyl fumarate; noDMT no disease-modifying therapy; total cerebral deep gray matter (DGM) = thalamus + caudate + putamen + globus pallidus; p values shown are with time between scans as a covariate; *p < 0.05